Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Liaquat University of Medical & Health Sciences clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy register with Liaquat University of Medical & Health Sciences as lead sponsor. Synced 17 Nov 2026
13Current trials
1Recruiting now
4Drugs in these trials
1Trial register
At a glance

Liaquat University of Medical & Health Sciences is the lead sponsor of 13 current clinical trials in our Italy register. 1 is recruiting patients now. All registered phases are Not applicable. The drugs named most often in its trials are Amoxicillin, Amoxicillin/Clavulanic Acid and Esomeprazole. The most-studied condition is Post-Colonoscopy Gastrointestinal Symptoms.

ClinicalTrials.gov trials by status

  • Recruiting18%
  • Not yet open1292%

Trials by phase

  • Not applicable13100%
01

Clinical trials sponsored by Liaquat University of Medical & Health Sciences

13 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis
NCT07474831 · ClinicalTrials.gov ↗ · Recurrent Bacterial Vaginosis
Not applicable Recruiting 2026-03 Italy
Mirgeal® Gel as Add-on Therapy to Esomeprazole in Adults With Non-Erosive Gastroesophageal Reflux Disease
NCT07790549 · ClinicalTrials.gov ↗ · Non-Erosive Gastroesophageal Reflux Disease (NERD)
Not applicable Not yet open 2026-09 Italy
Berberol P for Mild-to-Moderate Hypercholesterolaemia
NCT07789366 · ClinicalTrials.gov ↗ · Hypercholesterolemia
Not applicable Not yet open 2026-09 Italy
Evaluation of Bifidobacterium Breve PRL2020 in Preventing Antibiotic-Associated Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid
NCT06850714 · ClinicalTrials.gov ↗ · Antibiotic Side Effect
Not applicable Not yet open 2025-02 Italy
Pistacia Lentiscus Oil Nasal Spray With Reduced-Dose Mometasone in Chronic Rhinosinusitis
NCT07787494 · ClinicalTrials.gov ↗ · Chronic Rhinosinusitis (CRS)
Not applicable Not yet open 2026-09 Italy
Berberine Phytosome for Signs and Symptoms of Polycystic Ovary Syndrome (PCOS)
NCT07465575 · ClinicalTrials.gov ↗ · Polycystic Ovary Syndrome
Not applicable Not yet open 2026-03 Italy
Bactorinol® Nasal Spray With Reduced-Dose Mometasone in Adults With Chronic Rhinosinusitis
NCT07800273 · ClinicalTrials.gov ↗ · Chronic Rhinosinusitis
Not applicable Not yet open 2026-09 Italy
Probiotic Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use
NCT07936656 · ClinicalTrials.gov ↗ · Antibiotic-associated Diarrhea
Not applicable Not yet open 2026-11 Italy
Assessment of the Efficacy of E. Coli 5C in the Management of Post-Colonoscopy Symptoms
NCT07931365 · ClinicalTrials.gov ↗ · Post-Colonoscopy Gastrointestinal Symptoms
Not applicable Not yet open 2026-11 Italy
Assessment of the Efficacy of a Highly Standardized Ginger and Perilla Nutraceutical (Dispepril®) in Improving Gastric and Intestinal Symptoms in Patients With Functional Dyspepsia
NCT07655219 · ClinicalTrials.gov ↗ · Functional Dysphonia
Not applicable Not yet open 2026-06 Italy
Effect of Neurofast® Supplementation on Anxiety and Cardiovascular Outcomes in the Psycho-Cardio Phenotype Adults
NCT07502807 · ClinicalTrials.gov ↗ · Anxiety, Cardiovascular Diseases
Not applicable Not yet open 2026-04 Italy
Effect of Escherichia Coli 5C (Colipral®) on Post-Colonoscopy Gastrointestinal Symptoms
NCT07519616 · ClinicalTrials.gov ↗ · Post-Colonoscopy Gastrointestinal Symptoms
Not applicable Not yet open 2026-04 Italy
Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype
NCT07494279 · ClinicalTrials.gov ↗ · Prehypertension, Hypertension
Not applicable Not yet open 2026-03 Italy

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Liaquat University of Medical & Health Sciences trials

4 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Liaquat University of Medical & Health Sciences trials

14 conditions
Post-Colonoscopy Gastrointestinal Symptoms2Non-Erosive Gastroesophageal Reflux Disease (NERD)1Hypercholesterolemia1Antibiotic Side Effect1Chronic Rhinosinusitis (CRS)1Polycystic Ovary Syndrome1Chronic Rhinosinusitis1Antibiotic-associated Diarrhea1Functional Dysphonia1Anxiety1Cardiovascular Diseases1Recurrent Bacterial Vaginosis1Prehypertension1Hypertension1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Italy131

A trial with sites in more than one country appears in each of those registers.

05

Questions about Liaquat University of Medical & Health Sciences trials

How many clinical trials does Liaquat University of Medical & Health Sciences sponsor?

Liaquat University of Medical & Health Sciences is the lead sponsor of 13 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Liaquat University of Medical & Health Sciences trials recruiting?

Yes. 1 of its 13 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Liaquat University of Medical & Health Sciences testing?

Its current trials name 4 drugs and biologicals as interventions. The most frequent are Amoxicillin (1), Amoxicillin/Clavulanic Acid (1), Esomeprazole (1) and Mometasone furoate (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.